Chemistry:25F-NBOMe

From HandWiki

25F-NBOMe, also known as 2C-F-NBOMe or NBOMe-2C-F as well as N-(2-methoxybenzyl)-4-fluoro-2,5-dimethoxyphenethylamine, is a serotonin 5-HT2 receptor agonist and possible serotonergic psychedelic of the phenethylamine, 2C, and 25-NB (NBOMe) families.[1][2] It is the NBOMe (N-(2-methoxybenzyl)) derivative of 2C-F.[1][2]

25F-NBOMe activities
Target Affinity (Ki, nM)
5-HT1A ND
5-HT1B 6,331
5-HT1D 5,052
5-HT1E ND
5-HT1F ND
5-HT2A 3.3 (Ki)
16 (EC50)
75% (Emax)
5-HT2B 7.5 (Ki)
ND (EC50)
ND (Emax)
5-HT2C 43 (Ki) (rat)
25 (EC50)
92% (Emax)
5-HT3 ND
5-HT4 ND
5-HT5A ND
5-HT6 80
5-HT7 ND
α1Aα1D ND
α2Aα2C ND
β1β3 ND
D1–D5 ND
H1–H4 ND
M1–M5 ND
I1 ND
σ1, σ2 ND
ORs ND
TAAR1 ND
SERT ND (Ki)
ND (IC50)
ND (EC50)
NET ND (Ki)
ND (IC50)
ND (EC50)
DAT ND (Ki)
ND (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs: [1][2]

Pharmacology

Pharmacodynamics

25F-NBOMe acts as a potent agonist of the serotonin 5-HT2A and 5-HT2C receptors and also shows interactions with certain other targets, such as the serotonin 5-HT2B receptor.[1][2] However, it shows more than an order of magnitude lower potency as a serotonin 5-HT2A receptor agonist than certain other NBOMe drugs like 25I-NBOMe and 25B-NBOMe in vitro.[2]

History

25F-NBOMe was first described in the scientific literature by 2010.[1]

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 Hansen M (2010-12-16). Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen. doi:10.13140/RG.2.2.33671.14245.
  2. 2.0 2.1 2.2 2.3 2.4 "Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists". ACS Chemical Neuroscience 5 (3): 243–249. March 2014. doi:10.1021/cn400216u. PMID 24397362. 


Template:Psychedelics